Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I results demonstrate encouraging efficacy for D2C7-IT in malignant glioma

Nov. 22, 2018

Arcus presents novel small-molecule CD73 inhibitors for orally bioavailable cancer therapy

Nov. 22, 2018

REALIST study explores use of mesenchymal stem cells to treat ARDS

Nov. 22, 2018

New phase II/III study in Hong Kong investigates JCM-16021 for diarrhea-predominant IBS

Nov. 22, 2018

GlaxoSmithKline begins first-in-human study of GSK-3368715 in solid tumors and DLBCL

Nov. 22, 2018

AU-15506, a highly potent, selective inhibitor of CDK12 with oral efficacy in a TNBC model

Nov. 22, 2018

Final phase I/Ib study results with Pulmazole support advancement to phase II

Nov. 22, 2018

IBT amends planned phase III protocol for IBP-9414

Nov. 22, 2018

MDM2 degraders for anticancer therapy presented

Nov. 22, 2018

Discovery and characterization of novel potent and selective CD73 inhibitor A-001202

Nov. 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...